Assembly Biosciences Inc (NASDAQ:ASMB)
| 17.74 Delayed Data As of Feb 27 |  -2.15 / -10.81%Today’s Change | 8.13 Today|||52-Week Range 25.07 | -13.29% Year-to-Date |
Latest ASMB News | Press Releases
No recent news for Assembly Biosciences Inc.
Today’s Trading
| Previous close | 19.89 |
| Today’s open | 19.51 |
| Day’s range | 17.70 - 19.76 |
| Volume | 287,593 |
| Average volume (3 months) | 605,963 |
| Market cap | $682.8M |
Data as of 3:59pm ET, 02/27/2020
Growth & Valuation
| Earnings growth (last year) | -65.15% |
| Earnings growth (this year) | +5.90% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +64.15% |
| P/E ratio | NM |
| Price/Sales | 34.84 |
| Price/Book | 2.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| AKROAkero Therapeutics I... | -0.18 | -0.81% |
| GTHXG1 Therapeutics Inc | +0.35 | +2.00% |
| FLXNFlexion Therapeutics... | -0.80 | -4.90% |
Data as of 4:15pm ET, 02/27/2020
Financials
| Last reporting date | February 27, 2020 |
| EPS forecast (this quarter) | -$1.01 |
| Annual revenue (last year) | $14.8M |
| Annual profit (last year) | -$90.8M |
| Net profit margin | -613.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
